---
schema_version: "secwatch.filing_event.v1"
accession: "0000014272-25-000129"
form_type: "8-K"
ticker: "BMY"
cik: "0000014272"
company_name: "BRISTOL MYERS SQUIBB CO"
filed_at: "2025-07-31T23:59:59+00:00"
generated_at: "2026-05-17T22:15:33.757880+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# BMY Q2 revenue $12.3B, GAAP EPS $0.64, non-GAAP EPS $1.46; raises revenue guidance

## Summary
- Revenue $12.3B, +1% YoY; Growth Portfolio $6.6B, +18% YoY (+17% ex-FX).
- GAAP EPS $0.64 vs $0.83 YoY; non-GAAP EPS $1.46 vs $2.07 YoY, both hit by $(0.57) BioNTech IPRD charge.
- 2025 revenue guidance raised to ~$46.5B–$47.5B; non-GAAP EPS guidance updated to $6.35–$6.65.
- BioNTech strategic partnership resulted in a $0.57 per share Acquired IPRD charge in Q2.
- CEO cites strong Growth Portfolio execution, cost optimization, and pipeline partnerships.

## SEC filing metadata
- accession: 0000014272-25-000129
- form_type: 8-K
- ticker: BMY
- cik: 0000014272
- company_name: BRISTOL MYERS SQUIBB CO
- filed_at: 2025-07-31T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/14272/000001427225000129/0000014272-25-000129-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/14272/000001427225000129/bmy-20250731.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000014272-25-000129
- JSON: https://secwatch.observer/filing/0000014272-25-000129.json
- Plain text: https://secwatch.observer/filing/0000014272-25-000129.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.